Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9809561.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Positron emission tomography (PET) is now regularly used in the diagnosis and staging of cancer. These uses and its ability to monitor treatment response would be aided by the development of imaging agents that can be used to measure tissue and tumor proliferation. We have developed and tested [F-18]FLT (3'-deoxy-3'-fluorothymidine); it is resistant to degradation, is retained in proliferating tissues by the action of thymidine kinase 1 (TK), and produces high-contrast images of normal marrow and tumors in canine and human subjects.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Dideoxynucleosides
- Fluorine Radioisotopes
- Lung Neoplasms
- Tomography, Emission-Computed